HIGHLIGHTS
- who: C. Okhuijsen-Pfeifer from the Department of, University Medical Center Utrecht, Utrecht University, Brain Center, Utrecht, The Netherlands Department of Neuroscience, University have published the research: Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders, in the Journal: (JOURNAL) of 27/09/2021
- what: The aims of the study were to analyze the amount of variance in symptom severity among clozapine-treated patients explained by PRSs, to examine the association between symptom severity and genotype-predicted CYP1A2, CYP2D6, and CYP2C19 enzyme activity, and explore loci associated with symptom . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.